Market Insights Health Medical Technology Medical Devices

General & Plastic Surgery Devices - Eastern Asia

Eastern Asia

The General & Plastic Surgery Devices market market in Eastern Asia is anticipated to witness a significant increase in revenue, with projections indicating that it will reach US$3.77bn by the year 2024.
Moreover, it is expected to exhibit a steady annual growth rate of 7.01% from 2024 to 2029, ultimately leading to a market volume of US$5.29bn by the end of the forecast period.
When comparing the revenue generated globally, it is noteworthy that the United States is expected to generate the highest amount, with an estimated revenue of US$9,844.00m in 2024.
In Eastern Asia, the demand for General & Plastic Surgery Devices is driven by the region's growing middle class and increasing focus on aesthetic enhancements.

Key regions: Europe, Japan, United Kingdom, Netherlands, China

Market

Region

Region comparison

Currency

Analyst Opinion

The General & Plastic Surgery Devices market in Eastern Asia has been experiencing significant growth in recent years. Customer preferences for aesthetic procedures and advancements in technology are driving this growth. Additionally, local special circumstances and underlying macroeconomic factors have also contributed to the development of the market in this region. Customer preferences in Eastern Asia have shifted towards a greater emphasis on physical appearance and beauty. This has led to an increased demand for general and plastic surgery procedures. Consumers are seeking to enhance their features and improve their overall appearance, driving the demand for surgical devices in the market. Additionally, the influence of social media and celebrity culture has also played a role in shaping customer preferences, as individuals aspire to achieve the same level of beauty and perfection. Advancements in technology have also contributed to the growth of the General & Plastic Surgery Devices market in Eastern Asia. The region is known for its technological innovation and has witnessed significant developments in surgical devices. These advancements have improved the safety and efficacy of surgical procedures, making them more accessible and appealing to consumers. The introduction of minimally invasive techniques and the use of advanced imaging technologies have also contributed to the growth of the market, as they offer less invasive options with shorter recovery times. Local special circumstances in Eastern Asia have also influenced the development of the General & Plastic Surgery Devices market. Countries in this region, such as South Korea and Japan, have a strong beauty culture and place a high value on physical appearance. This cultural emphasis on beauty has created a conducive environment for the growth of the market, as individuals are more willing to invest in aesthetic procedures. Additionally, the presence of a well-developed healthcare infrastructure and a skilled workforce has also contributed to the growth of the market in this region. Underlying macroeconomic factors have also played a role in the development of the General & Plastic Surgery Devices market in Eastern Asia. The region has witnessed rapid economic growth and an increase in disposable income levels. This has allowed individuals to allocate a larger portion of their income towards aesthetic procedures, driving the demand for surgical devices. Additionally, the aging population in Eastern Asia has also contributed to the growth of the market, as individuals seek to address the signs of aging through surgical procedures. In conclusion, the General & Plastic Surgery Devices market in Eastern Asia is experiencing significant growth due to customer preferences for aesthetic procedures, advancements in technology, local special circumstances, and underlying macroeconomic factors. As the region continues to prioritize physical appearance and beauty, coupled with technological advancements and a favorable economic environment, the market is expected to continue its upward trajectory in the coming years.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.